Lv. Rao et al., Cost-effective utilization of CK-MB mass and activity assays - Evaluation of patients with chest pain in the emergency department, LAB MED, 30(4), 1999, pp. 271-275
Effective use of creatine kinase M and B isoform (CK-MB) test results for t
he diagnosis or exclusion of acute myocardial infarction (AMI) requires rep
eated analyses at defined intervals after the onset of chest pain. An incre
ase in serum CK-MB is evaluated relative to typical angina-like chest pain
of at least 30 minutes duration and electrocardiographic changes per World
Health Organization (WHO) standards, Two or more of the three findings must
be abnormal for the diagnosis of AMI. We assessed the appropriateness clin
ical usefulness) and cost-effectiveness of CK-MB mass and activity levels i
n the care of patients with complaints of chest pain seen in our emergency
department. The total CK and CK-MB (mass and activity) results for 860 pati
ents during 2 months in 1995 were reviewed retrospectively relative to the
discharge diagnosis. According to the discharge diagnoses based on the WHO
diagnostic criteria for AMI only 54 patients (6.3%) had acute myocardial in
farction. Three or more CK-MB tests (mass and activity measurements) were p
erformed in 60.5% of patients, and only one test was performed in the remai
ning 39.5%. Abnormal CK-MB mass or activity was determined with the followi
ng criteria: Protocol 1: CK-MB mass >5 ng/mL, total CK >194 U/L index >2.5%
; Protocol 2: CK-MB activity >16 U/L, total CI( >65 U/L, index >5%; Protoco
l 3: CK-MB activity >10 U/L, total CK >65 U/L, index >2.2%. Based on these
criteria, CK-MB mass and activity protocols gave positive predictive values
of 38.2%, 36.1%, and 35.4% for protocols 1, 2 and 3, respectively The nega
tive predictive value was 99% for CK MB mass (Protocol 1), and 98% and 98.9
% for CK-MB activity(Protocols 2 and 3). These results indicate that both C
K-MB mass and activity protocols have equivalent clinical usefulness. Howev
er, given the technologic limitation of two platforms for Protocol 1 vs one
assay platform for Protocols 2 and 3, the CK-MB activity protocol is more
cost-effective for patient testing in the emergency department laboratory.